HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapy of neuroleptic malignant syndrome.

Abstract
The neuroleptic malignant syndrome (NMS) is an under-recognized yet sometimes fatal complication of antipsychotic drug therapy. NMS is comprised of hyperthermia, rigidity, autonomic disturbances, and altered consciousness. Until recently, there was no specific therapy for NMS other than discontinuing the offending neuroleptic and providing symptomatic treatment. However, 4 drugs (dantrolene and the dopamine agonists amantadine, bromocriptine, and carbidopa/levodopa) have clearly emerged to merit consideration in the therapy of NMS. The literature on their use in this disorder, either alone or in combination, is reviewed. The combination of dantrolene (a peripheral muscle relaxant) and post-synaptic dopamine agonists may prove the most effective in this condition.
AuthorsA Lazarus
JournalPsychiatric developments (Psychiatr Dev) Vol. 4 Issue 1 Pg. 19-30 ( 1986) ISSN: 0262-9283 [Print] England
PMID3703852 (Publication Type: Journal Article)
Chemical References
  • Receptors, Dopamine
  • Bromocriptine
  • Levodopa
  • Amantadine
  • Dantrolene
  • Carbidopa
  • Diazepam
Topics
  • Amantadine (therapeutic use)
  • Bromocriptine (therapeutic use)
  • Carbidopa (therapeutic use)
  • Combined Modality Therapy
  • Dantrolene (therapeutic use)
  • Diazepam (therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Electroconvulsive Therapy
  • Humans
  • Levodopa (therapeutic use)
  • Neuroleptic Malignant Syndrome (drug therapy)
  • Receptors, Dopamine (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: